Hepatitis C virus reveals a novel early control in acute immune response.

Publisher: Public Library of Science Country of Publication: United States NLM ID: 101238921 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1553-7374 (Electronic) Linking ISSN: 15537366 NLM ISO Abbreviation: PLoS Pathog Subsets: MEDLINE

Original Publication: San Francisco, CA : Public Library of Science, c2005-

Cytokines/*metabolism ; Hepacivirus/*immunology ; Hepacivirus/*metabolism ; Interferons/*biosynthesis ; Receptors, Retinoic Acid/*metabolism ; Ubiquitins/*metabolism ; eIF-2 Kinase/*metabolism; Adaptor Proteins, Signal Transducing/biosynthesis ; Adaptor Proteins, Signal Transducing/genetics ; Adaptor Proteins, Signal Transducing/metabolism ; Cell Line ; Cytokines/biosynthesis ; Cytokines/genetics ; Gene Expression Profiling ; Hepacivirus/genetics ; Hepatocytes/metabolism ; Hepatocytes/pathology ; Hepatocytes/virology ; Humans ; Interferon Regulatory Factor-3/biosynthesis ; Interferon Regulatory Factor-3/genetics ; Interferon Regulatory Factor-3/metabolism ; Interferons/genetics ; RNA Interference ; RNA, Small Interfering ; RNA, Viral/metabolism ; Receptors, Retinoic Acid/biosynthesis ; Receptors, Retinoic Acid/genetics ; Signal Transduction ; TNF Receptor-Associated Factor 3/biosynthesis ; TNF Receptor-Associated Factor 3/genetics ; TNF Receptor-Associated Factor 3/metabolism ; Ubiquitination ; Ubiquitins/biosynthesis ; Ubiquitins/genetics ; eIF-2 Kinase/biosynthesis ; eIF-2 Kinase/genetics

Recognition of viral RNA structures by the intracytosolic RNA helicase RIG-I triggers induction of innate immunity. Efficient induction requires RIG-I ubiquitination by the E3 ligase TRIM25, its interaction with the mitochondria-bound MAVS protein, recruitment of TRAF3, IRF3- and NF-κB-kinases and transcription of Interferon (IFN). In addition, IRF3 alone induces some of the Interferon-Stimulated Genes (ISGs), referred to as early ISGs. Infection of hepatocytes with Hepatitis C virus (HCV) results in poor production of IFN despite recognition of the viral RNA by RIG-I but can lead to induction of early ISGs. HCV was shown to inhibit IFN production by cleaving MAVS through its NS3/4A protease and by controlling cellular translation through activation of PKR, an eIF2α-kinase containing dsRNA-binding domains (DRBD). Here, we have identified a third mode of control of IFN induction by HCV. Using HCVcc and the Huh7.25.CD81 cells, we found that HCV controls RIG-I ubiquitination through the di-ubiquitine-like protein ISG15, one of the early ISGs. A transcriptome analysis performed on Huh7.25.CD81 cells silenced or not for PKR and infected with JFH1 revealed that HCV infection leads to induction of 49 PKR-dependent genes, including ISG15 and several early ISGs. Silencing experiments revealed that this novel PKR-dependent pathway involves MAVS, TRAF3 and IRF3 but not RIG-I, and that it does not induce IFN. Use of PKR inhibitors showed that this pathway requires the DRBD but not the kinase activity of PKR. We then demonstrated that PKR interacts with HCV RNA and MAVS prior to RIG-I. In conclusion, HCV recruits PKR early in infection as a sensor to trigger induction of several IRF3-dependent genes. Among those, ISG15 acts to negatively control the RIG-I/MAVS pathway, at the level of RIG-I ubiquitination.These data give novel insights in the machinery involved in the early events of innate immune response.

Proc Natl Acad Sci U S A. 2005 Jul 19;102(29):10200-5. (PMID: 16009940)
Mol Cell Biol. 2004 May;24(10):4502-12. (PMID: 15121867)
J Virol. 2005 Aug;79(15):9369-80. (PMID: 16014900)
Cell Signal. 2006 Nov;18(11):1865-75. (PMID: 16600570)
Nature. 1979 Jun 7;279(5713):523-5. (PMID: 571963)
J Virol. 2007 May;81(10):5036-45. (PMID: 17329343)
Proc Natl Acad Sci U S A. 1985 Jul;82(13):4341-5. (PMID: 3859866)
J Virol. 2005 Apr;79(7):3920-9. (PMID: 15767394)
Innate Immun. 2010 Oct;16(5):322-32. (PMID: 19822632)
Gastroenterology. 2005 May;128(5):1437-44. (PMID: 15887125)
J Virol. 2007 Nov;81(22):12227-37. (PMID: 17804509)
J Biol Chem. 2009 Jan 16;284(3):1644-51. (PMID: 19028691)
Biochim Biophys Acta. 2010 May;1802(5):485-96. (PMID: 20153823)
Lab Invest. 2004 Sep;84(9):1148-59. (PMID: 15208644)
Hepatology. 2010 May;51(5):1523-30. (PMID: 20186843)
PLoS One. 2010 May 11;5(5):e10575. (PMID: 20485506)
Nature. 2007 Apr 19;446(7138):916-920. (PMID: 17392790)
J Med Virol. 2004 Jun;73(2):187-94. (PMID: 15122791)
Proc Natl Acad Sci U S A. 2006 Jul 11;103(28):10735-40. (PMID: 16815975)
Gut. 2008 Apr;57(4):516-24. (PMID: 17895355)
Peptides. 2000 Oct;21(10):1449-56. (PMID: 11068090)
Nature. 2006 Jan 12;439(7073):208-11. (PMID: 16306936)
Protein Cell. 2010 Dec;1(12):1106-17. (PMID: 21213104)
J Virol. 2008 Feb;82(3):1474-83. (PMID: 18057259)
J Biol Chem. 2003 May 9;278(19):16608-13. (PMID: 12582176)
Immunol Rev. 2009 Jan;227(1):54-65. (PMID: 19120475)
J Biol Chem. 2006 Feb 17;281(7):3989-94. (PMID: 16352599)
Science. 2007 Nov 30;318(5855):1455-8. (PMID: 18048689)
J Virol. 2001 Aug;75(15):7059-66. (PMID: 11435586)
Mol Cell Biol. 2006 Jan;26(2):472-9. (PMID: 16382139)
Toxicol In Vitro. 2010 Feb;24(1):85-91. (PMID: 19737606)
Methods Mol Biol. 2010;640:431-45. (PMID: 20645066)
Virology. 2006 Jul 20;351(1):101-11. (PMID: 16631220)
Gut. 2010 Aug;59(8):1111-9. (PMID: 20639253)
J Virol. 2004 Dec;78(24):13779-92. (PMID: 15564486)
Nature. 2008 Jul 24;454(7203):523-7. (PMID: 18548002)
J Virol. 2002 Jun;76(11):5532-9. (PMID: 11991981)
Proc Natl Acad Sci U S A. 2008 May 13;105(19):7034-9. (PMID: 18467494)
Hepatology. 2007 Nov;46(5):1365-74. (PMID: 17668876)
Mol Cell. 2010 Jun 11;38(5):722-32. (PMID: 20542004)
Proc Natl Acad Sci U S A. 2008 Oct 28;105(43):16743-8. (PMID: 18948594)
Chem Biol. 1997 Feb;4(2):139-47. (PMID: 9190288)
Antiviral Res. 2009 Sep;83(3):228-37. (PMID: 19467267)
J Gen Virol. 2010 Feb;91(Pt 2):382-8. (PMID: 19846672)
EMBO J. 2001 Feb 1;20(3):362-71. (PMID: 11157743)
Cell Host Microbe. 2009 Dec 17;6(6):513-22. (PMID: 20006840)
J Immunol. 2010 Jul 15;185(2):1158-68. (PMID: 20554965)
Nat Rev Microbiol. 2005 Oct;3(10):799-808. (PMID: 16175175)
J Biol Chem. 1987 Aug 15;262(23):11315-23. (PMID: 2440890)
J Virol. 2010 Jan;84(1):380-6. (PMID: 19846517)
J Virol. 2005 Mar;79(5):2689-99. (PMID: 15708988)
Proc Natl Acad Sci U S A. 2010 Apr 20;107(16):7431-6. (PMID: 20231459)
J Biol Chem. 2008 Dec 12;283(50):34580-7. (PMID: 18927075)
Nature. 2005 Oct 20;437(7062):1167-72. (PMID: 16177806)
Proc Natl Acad Sci U S A. 2006 Apr 11;103(15):6001-6. (PMID: 16585524)
Biochem Biophys Res Commun. 2007 Mar 2;354(1):321-7. (PMID: 17222803)
Biochem Biophys Res Commun. 2003 Aug 15;308(1):50-7. (PMID: 12890478)

0 (Adaptor Proteins, Signal Transducing)
0 (Cytokines)
0 (IRF3 protein, human)
0 (Interferon Regulatory Factor-3)
0 (MAVS protein, human)
0 (PLAAT4 protein, human)
0 (RNA, Small Interfering)
0 (RNA, Viral)
0 (Receptors, Retinoic Acid)
0 (TNF Receptor-Associated Factor 3)
0 (TRAF3 protein, human)
0 (Ubiquitins)
60267-61-0 (ISG15 protein, human)
9008-11-1 (Interferons)
EC 2.7.11.1 (eIF-2 Kinase)

Date Created: 20111025 Date Completed: 20120416 Latest Revision: 20211020

20240829

PMC3192838

10.1371/journal.ppat.1002289

22022264